Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecally Administered Ketamine, Dexmedetomidine, and Their Combination With Bupivacaine for Postoperative Analgesia in Major Abdominal Cancer Surgery

NCT02455609 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT02455609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02455609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecally Administered Ketamine, Dexmedetomidine, and Their Combination With Bupivacaine for Postoperative Analgesia in Major Abdominal Cancer Surgery
Lead sponsor
Assiut University
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 31, 2015
Completion date
September 30, 2015
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pain management, therapy